World News TV Breaking
[BREAKING] [Breaking news] HLB decides to approve the first U.S. (FDA) liver cancer drug, riboceranib, a new drug for the world's global new drug company "Woo-Tuk."
2 February Share
[BREAKING] [Breaking news] HLB decides to approve the first U.S. (FDA) liver cancer drug, riboceranib, a new drug for the world's global new drug company "Woo-Tuk."
【速報】HLB、韓国初の米(FDA)肝臓がん治療剤リボセラニブ新薬許可「承認決定」世界のグローバル新薬会社「ウトゥク」
[速报]HLB获得国内首家美国(FDA)肝癌治疗剂阿帕替尼的新药许可，全球全球新药公司"高耸"
[Срочные новости] Эйчелби, первый в Корее препарат для лечения рака печени (FDA) рибоцераниб «решение об одобрении» нового препарата «Утук» Глобальная компания по новым лекарствам «Утук»
[속보] 에이치엘비, 국내 최초 미(FDA) 간암 치료제 리보세라닙 신약 허가 “승인 결정” 세계 글로벌 신약회사 ‘우뚝’ [More News]
The message left by this news reporter
「[Breaking news] HLB decides to approve the first U.S. (FDA) liver cancer drug, riboceranib, a new drug for the world's global new drug company "Woo-Tuk."」
| There are 0 comments in total |